August 2019 – Page 7 – Pharma News HQ

June 16, 2025

Top Headlines

[ February 14, 2023 ] Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues Manufacturing
[ February 14, 2023 ] Genenta Science signs manufacturing deal with AGC Biologics Manufacturing
[ February 14, 2023 ] Vial and Egnyte announce partnership for eTMF solution integration Clinical Trials
[ February 14, 2023 ] SOPHiA GENETICS and AstraZeneca partner for oncology drugs development Drug Development
[ February 14, 2023 ] FDA suggests ways to curb constraints with rare disease gene therapy trials Clinical Trials

Exelixis, Aurigene strike deal to discover and develop novel therapies for cancer

August 7, 2019 Pharma News HQ 0

Exelixis, Inc. announced that it has entered into an exclusive collaboration, option and license agreement with Aurigene Discovery Technologies Limited (Aurigene), the India-based discovery biotechnology company focused on oncology and inflammatory disorders. The agreement gives […]

Roche’s Tecentriq plus platinum-based chemotherapy improves PFS in bladder cancer study

August 7, 2019 Pharma News HQ 0

Roche has announced that its Tecentriq (atezolizumab) plus platinum-based chemotherapy has significantly reduced the risk of disease worsening or death in people with previously untreated advanced bladder cancer in the phase III IMvigor130 study. The […]